Skip to main content
Medistim logo

Medistim — Investor Relations & Filings

Ticker · MEDI ISIN · NO0010159684 LEI · 5967007LIEEXZXJOX483 OL Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2024-04-02 Annual Report
Country NO Norway
Listing OL MEDI

About Medistim

https://medistim.com/

Medistim is a medical technology company specializing in intraoperative quality assessment solutions. A pioneer and market leader in Transit Time Flow Measurement (TTFM), the company develops and manufactures advanced medical devices for use during surgical procedures. Its flagship MiraQ™ system uniquely combines TTFM with high-frequency ultrasound imaging, providing surgeons with real-time data to verify graft function and blood flow. This technology is applied in cardiac, vascular, and transplant surgery to enhance procedural quality control and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Notice of Annual General Meeting in Medistim ASA
Annual Report Classification · 100% confidence The document is a comprehensive annual report for Medistim, containing a letter from the CEO, board of director's report, corporate governance report, sustainability report, and full consolidated financial statements for both the group and the parent company. It covers the entire fiscal year's performance and activities, fitting the definition of an Annual Report (10-K). FY 2023
2024-04-02 English
Notice of Annual General Meeting in Medistim ASA
Annual Report Classification · 100% confidence The document is titled '2023 CORPORATE ANNUAL REPORT' and contains comprehensive sections typical of an annual report, including a letter from the CEO, executive management and board of directors information, a detailed operational and financial review, corporate governance report, sustainability report, consolidated and parent company financial statements, notes to the accounts, alternative performance measures, and an auditor's report. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The content covers the full fiscal year 2023, with detailed financial data and management discussion. Therefore, this document fits the definition of an Annual Report (10-K). FY 2023
2024-04-02 Norwegian
Notice of Annual General Meeting in Medistim ASA
AGM Information Classification · 98% confidence The document is explicitly titled 'Notice of Annual General Meeting in Medistim ASA' and announces the date, time, and location for the AGM. It states that the agenda, voting form, and the annual report are 'Attached'. Because this document is a notice/announcement about the AGM and includes attachments rather than being the full presentation or the full annual report itself, it fits the definition of AGM Information (AGM-R). Although it mentions the annual report is attached, the primary purpose and title relate to the meeting itself.
2024-04-02 English
Financial statements for 2023 for Medistim ASA – Correction
Annual Report Classification · 100% confidence The document is a comprehensive annual report for Medistim, containing a letter from the CEO, board of director's report, corporate governance report, sustainability report, and full consolidated financial statements for both the group and the parent company. It covers the entire fiscal year's performance and activities, fitting the definition of an Annual Report (10-K). FY 2023
2024-03-25 English
Financial statements for 2023 for Medistim ASA – Correction
Annual Report Classification · 100% confidence The document is titled '2023 CORPORATE ANNUAL REPORT' for Medistim ASA and contains extensive sections typical of a full annual report, including a letter from the CEO, management and board details, operational and financial reviews, corporate governance, sustainability report, consolidated and parent company financial statements, notes to accounts, and an auditor's report. The length is substantial (15,000 characters) and it includes detailed financial data and comprehensive company information for the fiscal year 2023. This matches the definition of an Annual Report (10-K). FY 2023
2024-03-25 English
Financial statements for 2023 for Medistim ASA – Correction
Report Publication Announcement Classification · 98% confidence The document text is very short (365 characters) and explicitly states that a previously published document (Financial statements for 2023) is being corrected because it 'missed page 3 in the auditors report.' It concludes by stating, 'attached is the financial statements for 2023 including the complete auditors report.' This structure—a brief announcement correcting and re-issuing a full report—fits the definition of a Report Publication Announcement (RPA), as it is announcing the publication/re-publication of the corrected financial statements, rather than being the full financial statements themselves (which would likely be classified as 10-K or AR if comprehensive). Since it is announcing the publication of a corrected report, RPA is the most appropriate code based on the 'MENU VS MEAL' rule.
2024-03-25 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.